{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:03:37Z","timestamp":1790892217543,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.urology.2004.10.077","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T15:03:14Z","timestamp":1113490994000},"page":"670-674","source":"Crossref","is-referenced-by-count":110,"title":["Prostate botulinum A toxin injection\u2014an alternative treatment for benign prostatic obstruction in poor surgical candidates"],"prefix":"10.1016","volume":"65","author":[{"given":"Hann-Chorng","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2004.10.077_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia","volume":"335","author":"Lepor","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2004.10.077_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0090-4295(98)00094-6","article-title":"Long-term effects of finasteride in patients with benign prostatic hyperplasia","volume":"51","author":"Marberger","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.10.077_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2004.10.077_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/01.ju.0000129967.30558.ca","article-title":"Transurethral microwave thermotherapy for benign prostate hyperplasia","volume":"172","author":"Walmsley","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.ju.0000054657.59200.97","article-title":"A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia","volume":"169","author":"van Melick","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/01.ju.0000134884.18722.9c","article-title":"Transurethral ethanol injection therapy for prostatic hyperplasia","volume":"172","author":"Goya","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.45.4.712","article-title":"Botulinum toxin A for spasticity, muscle spasms, and rigidity","volume":"45","author":"Grazko","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.urology.2004.10.077_bib8","first-page":"24","article-title":"Treatment of detrusor sphincter dyssynergia with botulinum A toxin","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehab"},{"key":"10.1016\/j.urology.2004.10.077_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum A toxin as a treatment of detrusor sphincter dyssynergia","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0090-4295(02)02541-4","article-title":"Clinical effect of botulinum A toxin for the treatment of voiding dysfunction due to detrusor underactivity","volume":"61","author":"Kuo","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.10.077_bib11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.10.077_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"suppl","key":"10.1016\/j.urology.2004.10.077_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-5347(18)38732-9","article-title":"Botulinum toxin A improves refractory benign prostatic hyperplasia symptoms","volume":"171","author":"Chung","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6777(1997)16:1<1::AID-NAU1>3.0.CO;2-I","article-title":"Standardisation on terminology of lower urinary tract function","volume":"16","author":"Griffiths","year":"1997","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2004.10.077_bib16","series-title":"Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27\u201330, 1993","first-page":"553","article-title":"Recommendation of the International Consensus Committee concerning: 1. Prostate symptom score and quality of life assessment","author":"Cockett","year":"1994"},{"key":"10.1016\/j.urology.2004.10.077_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendation","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0090-4295(97)00185-4","article-title":"Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia","volume":"49","author":"Andersen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.10.077_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pros.2990150503","article-title":"Studies of the structure and intrinsic innervation of the normal human prostate","volume":"2","author":"Higgins","year":"1989","journal-title":"Prostate Suppl"},{"key":"10.1016\/j.urology.2004.10.077_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-5347(17)49636-4","article-title":"Characterization and localization of the muscarinic cholinergic receptor in human prostate tissue","volume":"132","author":"Lepor","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.10.077_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000030497","article-title":"Pathophysiology of lower urinary tract symptoms in aged men without bladder outlet obstruction","volume":"64","author":"Kuo","year":"2000","journal-title":"Urol Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504013342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504013342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T05:58:46Z","timestamp":1550037526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429504013342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0090429504013342"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2004.10.077","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}